INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 49 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $81,000 | +28.6% | 69,548 | 0.0% | 0.01% | +18.2% |
| Q2 2020 | $63,000 | +8.6% | 69,548 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $58,000 | -13.4% | 69,548 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $67,000 | -6.9% | 69,548 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $72,000 | -42.4% | 69,548 | 0.0% | 0.01% | -43.5% |
| Q2 2019 | $125,000 | -4.6% | 69,548 | 0.0% | 0.02% | -8.0% |
| Q1 2019 | $131,000 | +219.5% | 69,548 | +98.7% | 0.02% | +177.8% |
| Q4 2018 | $41,000 | -56.8% | 35,000 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $95,000 | – | 35,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |